#68 - Talia Eisenberg: Ibogaine 101#68 - Talia Eisenberg: Ibogaine 101
Root Medicine
Eamon Armstrong interviews ibogaine clinic co-founder Talia Eisenberg about her journey from opiate dependence to working with this demanding medicine. They discuss ibogaine’s effects, medical risks, research momentum, and why preparation, safety and long-term integration are crucial for anyone considering it.
49:35•5 Nov 2026
Ibogaine 101 with Talia Eisenberg: From Opiates to Purpose
Episode Overview
- Ibogaine can rapidly reduce cravings and withdrawal in opiate dependence, but it brings underlying issues like anxiety back to the surface for longer-term work.
- The recent US executive order accelerates ibogaine research and coordination between agencies, but it does not legalise the medicine.
- Ibogaine affects multiple brain receptors and appears to open an extended “critical period” for learning new habits and dropping harmful ones.
- Cardiac risk is significant; thorough screening, continuous monitoring and experienced medical staff are essential for safer treatment.
- Lasting change relies on integration: coaching, community, daily practices and honest engagement with grief, shame and past trauma.
“"She said to me, 'Get your life together. Stop poisoning yourself. Make yourself of use to this world.'"”
Curious about how others navigate their sobriety journey? This conversation between producer and temporary host Eamon Armstrong and ibogaine clinic co-founder Talia Eisenberg lays out a grounded, no-nonsense introduction to ibogaine for people curious about its role in addiction recovery and mental health. Talia shares how an early, unregulated ibogaine experience in Mexico changed the course of her life.
Coming off years of opiate dependence that began with prescribed OxyContin, she describes feeling “like my brain was being erased” and seeing a fierce vision of her late grandmother, an Auschwitz survivor, telling her, “Get your life together. Stop poisoning yourself. Make yourself of use to this world.” That moment marked a turning point away from opiates, alcohol and stimulants, and towards service.
From there, the episode breaks down what ibogaine actually is, how it differs from other psychedelics like ayahuasca, and why it’s used for substance use disorder, PTSD, depression, anxiety and personal growth. Eamon and Talia touch on the recent US executive order that speeds up ibogaine research and clinical trials, and the landmark Stanford study on veterans with traumatic brain injury and PTSD. The discussion doesn’t shy away from risk.
Talia explains the cardiac dangers, why people have died in unsafe settings, and how her Cancun clinic Beond uses intensive screening, 24/7 medical care and cardiac monitoring to reduce those risks. She also walks through flood doses versus newer fractional dosing, and stresses that ibogaine is “not a recreational psychedelic” and definitely not something to try at home.
Integration gets as much attention as the drug itself: daily rituals, gratitude circles, ongoing coaching, community support and the reminder that “you don’t always feel better right away.” For parents with a child who’s using, Talia offers a simple message: there is hope, and ibogaine is one powerful tool among many. If you’ve ever wondered whether a single, intense experience can genuinely shift cravings, habits and purpose, this is a thoughtful place to start asking questions.
Do you want to link to this podcast?
Get the buttons here!
More From This Show
The latest episodes from the same podcast.